Fighting obesity the Franco-British way

Butabindide, designed by scientists in the UK and France, is one potential new anti-obesity drug that is attracting attention from pharmaceutical companies. This drug regulates appetite in experimental animals, but it has not yet been found suitable for humans.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1996-06, Vol.347 (9017), p.1756-1756
Main Author: Jack, DavidB
Format: Article
Language:English
Subjects:
Adolescent
Adult
Animals
Drug therapy
Drugs
Female
France
Humans
Indoles - therapeutic use
Male
Middle Aged
Obesity
Obesity - complications
Obesity - drug therapy
Pharmaceutical industry
Pharmacology
Protease Inhibitors - therapeutic use
United Kingdom
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Butabindide, designed by scientists in the UK and France, is one potential new anti-obesity drug that is attracting attention from pharmaceutical companies. This drug regulates appetite in experimental animals, but it has not yet been found suitable for humans.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(96)90825-9